Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles

Jaehong Key, Kwang Meyung Kim, Deepika Dhawan, Deborah W. Knapp, Ick Chan Kwon, Kuiwon Choi, James F. Leary

Research output: Chapter in Book/Report/Conference proceedingConference contribution

6 Citations (Scopus)

Abstract

Magnetic resonance imaging (MRI) is one of the best imaging modalities for noninvasive cancer detection but MRI does not have enough sensitivity to delineate tumor margins during surgery. Moreover, since most surgical tools contain metal substances, image-guided surgery is hard to perform with a MR machine using magnets. Also, MR imaging is too slow for real-time guided-surgery. On the other hand, near infrared fluorescence (NIRF) imaging has recently received great interest for in vivo imaging due to its high signal-to-noise ratios and short image-acquisition times. NIRF imaging can be used to delineate tumor margins during surgery, but current NIRF imaging cannot provide the penetration depth to detect early-stage cancer inside body. Thus, we have developed dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. NIRF dye (cyanine 5.5, Cy5.5), conjugated glycol chitosan nanoparticles (HGC) exhibited excellent tumor targeting ability with NIRF imaging. Superparamagnetic iron oxide (SPIO) nanoparticles as a MR contrast agent were loaded into the nanoparticles, resulting in SPIO-HGC-Cy5.5 nanoparticles. SPIO-HGC-Cy5.5 nanoparticles were characterized and evaluated in mice by both NIRF and MR imaging. Our results indicate SPIO-HGC-Cy5.5 nanoparticles have the potential for dual-modality in vivo imaging with MRI detection of tumors and NIRF-guided surgery.

Original languageEnglish
Title of host publicationProgress in Biomedical Optics and Imaging - Proceedings of SPIE
Volume7908
DOIs
Publication statusPublished - 2011 Apr 1
Externally publishedYes
EventNanoscale Imaging, Sensing, and Actuation for Biomedical Applications VIII - San Francisco, CA, United States
Duration: 2011 Jan 242011 Jan 27

Other

OtherNanoscale Imaging, Sensing, and Actuation for Biomedical Applications VIII
CountryUnited States
CitySan Francisco, CA
Period11/1/2411/1/27

Fingerprint

surgery
Nanoparticles
Magnetic resonance imaging
Surgery
magnetic resonance
Tumors
Optical Imaging
tumors
Fluorescence
Magnetic Resonance Imaging
Infrared radiation
Imaging techniques
fluorescence
nanoparticles
iron oxides
Neoplasms
Iron oxides
margins
Computer-Assisted Surgery
cancer

ASJC Scopus subject areas

  • Atomic and Molecular Physics, and Optics
  • Electronic, Optical and Magnetic Materials
  • Biomaterials
  • Radiology Nuclear Medicine and imaging

Cite this

Key, J., Kim, K. M., Dhawan, D., Knapp, D. W., Kwon, I. C., Choi, K., & Leary, J. F. (2011). Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE (Vol. 7908). [790805] https://doi.org/10.1117/12.874241

Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. / Key, Jaehong; Kim, Kwang Meyung; Dhawan, Deepika; Knapp, Deborah W.; Kwon, Ick Chan; Choi, Kuiwon; Leary, James F.

Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7908 2011. 790805.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Key, J, Kim, KM, Dhawan, D, Knapp, DW, Kwon, IC, Choi, K & Leary, JF 2011, Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. in Progress in Biomedical Optics and Imaging - Proceedings of SPIE. vol. 7908, 790805, Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications VIII, San Francisco, CA, United States, 11/1/24. https://doi.org/10.1117/12.874241
Key J, Kim KM, Dhawan D, Knapp DW, Kwon IC, Choi K et al. Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. In Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7908. 2011. 790805 https://doi.org/10.1117/12.874241
Key, Jaehong ; Kim, Kwang Meyung ; Dhawan, Deepika ; Knapp, Deborah W. ; Kwon, Ick Chan ; Choi, Kuiwon ; Leary, James F. / Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. Progress in Biomedical Optics and Imaging - Proceedings of SPIE. Vol. 7908 2011.
@inproceedings{d43c6890e8c445e6a6659333b38b75aa,
title = "Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles",
abstract = "Magnetic resonance imaging (MRI) is one of the best imaging modalities for noninvasive cancer detection but MRI does not have enough sensitivity to delineate tumor margins during surgery. Moreover, since most surgical tools contain metal substances, image-guided surgery is hard to perform with a MR machine using magnets. Also, MR imaging is too slow for real-time guided-surgery. On the other hand, near infrared fluorescence (NIRF) imaging has recently received great interest for in vivo imaging due to its high signal-to-noise ratios and short image-acquisition times. NIRF imaging can be used to delineate tumor margins during surgery, but current NIRF imaging cannot provide the penetration depth to detect early-stage cancer inside body. Thus, we have developed dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. NIRF dye (cyanine 5.5, Cy5.5), conjugated glycol chitosan nanoparticles (HGC) exhibited excellent tumor targeting ability with NIRF imaging. Superparamagnetic iron oxide (SPIO) nanoparticles as a MR contrast agent were loaded into the nanoparticles, resulting in SPIO-HGC-Cy5.5 nanoparticles. SPIO-HGC-Cy5.5 nanoparticles were characterized and evaluated in mice by both NIRF and MR imaging. Our results indicate SPIO-HGC-Cy5.5 nanoparticles have the potential for dual-modality in vivo imaging with MRI detection of tumors and NIRF-guided surgery.",
author = "Jaehong Key and Kim, {Kwang Meyung} and Deepika Dhawan and Knapp, {Deborah W.} and Kwon, {Ick Chan} and Kuiwon Choi and Leary, {James F.}",
year = "2011",
month = "4",
day = "1",
doi = "10.1117/12.874241",
language = "English",
isbn = "9780819484451",
volume = "7908",
booktitle = "Progress in Biomedical Optics and Imaging - Proceedings of SPIE",

}

TY - GEN

T1 - Dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles

AU - Key, Jaehong

AU - Kim, Kwang Meyung

AU - Dhawan, Deepika

AU - Knapp, Deborah W.

AU - Kwon, Ick Chan

AU - Choi, Kuiwon

AU - Leary, James F.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Magnetic resonance imaging (MRI) is one of the best imaging modalities for noninvasive cancer detection but MRI does not have enough sensitivity to delineate tumor margins during surgery. Moreover, since most surgical tools contain metal substances, image-guided surgery is hard to perform with a MR machine using magnets. Also, MR imaging is too slow for real-time guided-surgery. On the other hand, near infrared fluorescence (NIRF) imaging has recently received great interest for in vivo imaging due to its high signal-to-noise ratios and short image-acquisition times. NIRF imaging can be used to delineate tumor margins during surgery, but current NIRF imaging cannot provide the penetration depth to detect early-stage cancer inside body. Thus, we have developed dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. NIRF dye (cyanine 5.5, Cy5.5), conjugated glycol chitosan nanoparticles (HGC) exhibited excellent tumor targeting ability with NIRF imaging. Superparamagnetic iron oxide (SPIO) nanoparticles as a MR contrast agent were loaded into the nanoparticles, resulting in SPIO-HGC-Cy5.5 nanoparticles. SPIO-HGC-Cy5.5 nanoparticles were characterized and evaluated in mice by both NIRF and MR imaging. Our results indicate SPIO-HGC-Cy5.5 nanoparticles have the potential for dual-modality in vivo imaging with MRI detection of tumors and NIRF-guided surgery.

AB - Magnetic resonance imaging (MRI) is one of the best imaging modalities for noninvasive cancer detection but MRI does not have enough sensitivity to delineate tumor margins during surgery. Moreover, since most surgical tools contain metal substances, image-guided surgery is hard to perform with a MR machine using magnets. Also, MR imaging is too slow for real-time guided-surgery. On the other hand, near infrared fluorescence (NIRF) imaging has recently received great interest for in vivo imaging due to its high signal-to-noise ratios and short image-acquisition times. NIRF imaging can be used to delineate tumor margins during surgery, but current NIRF imaging cannot provide the penetration depth to detect early-stage cancer inside body. Thus, we have developed dual-modality in vivo imaging for MRI detection of tumors and NIRF-guided surgery using multi-component nanoparticles. NIRF dye (cyanine 5.5, Cy5.5), conjugated glycol chitosan nanoparticles (HGC) exhibited excellent tumor targeting ability with NIRF imaging. Superparamagnetic iron oxide (SPIO) nanoparticles as a MR contrast agent were loaded into the nanoparticles, resulting in SPIO-HGC-Cy5.5 nanoparticles. SPIO-HGC-Cy5.5 nanoparticles were characterized and evaluated in mice by both NIRF and MR imaging. Our results indicate SPIO-HGC-Cy5.5 nanoparticles have the potential for dual-modality in vivo imaging with MRI detection of tumors and NIRF-guided surgery.

UR - http://www.scopus.com/inward/record.url?scp=79953134411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953134411&partnerID=8YFLogxK

U2 - 10.1117/12.874241

DO - 10.1117/12.874241

M3 - Conference contribution

SN - 9780819484451

VL - 7908

BT - Progress in Biomedical Optics and Imaging - Proceedings of SPIE

ER -